Literature DB >> 15996076

Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis.

Nandita Saxena1, Amita Aggarwal, Ramnath Misra.   

Abstract

OBJECTIVE: Cytokines are the major mediators of joint damage in chronic arthritis. Data on synovial fluid (SF) cytokine concentrations in patients with juvenile idiopathic arthritis (JIA), especially enthesitis related arthritis (ERA), are limited. We measured levels of different monocyte derived cytokines, T cell derived cytokines, and a proinflammatory chemokine in SF specimens from children with ERA or polyarticular (Poly) rheumatoid factor (RF)-negative JIA.
METHODS: Macrophage products [tumor necrosis factor-a (TNF-a), interleukin 1ss (IL-1ss), IL-6, IL-12p40)], T lymphocyte products [IL-2, IL-4, interferon-g (IFN-g)], and a proinflammatory chemokine (IL-8) were assayed using ELISA in SF specimens from 53 patients with JIA [ERA 34, polyarticular RF-negative 19] and 40 patients with rheumatoid arthritis (RA).
RESULTS: In the ERA group, median SF cytokine levels were higher compared to RA (all values are pg/ml): IL-1ss [< 15.6 (< 15.6-213) vs < 15.6 (< 15.6-41); p < 0.01], IL-12p40 [236 (< 15.6-1714) vs 21 (< 15.6-520); p < 0.0001], and IL-6 [1139 (< 4.6-2187) vs 835 (< 4.6-875); p < 0.0001]. TNF-a and IFN-g levels were similar to RA. IL-8 levels were significantly less than RA (p < 0.0001). The median levels of IL-1ss [39.4 (< 15.6-558) vs < 15.6 (< 15.6-41); p < 0.0001] and IL-12p40 [209 (< 15.6-849) vs 21 (< 15.6-520); p < 0.0001] were higher in patients with Poly-JIA compared to RA. TNF-a, IL-6, and IL-8 levels in Poly-JIA were comparable to RA. IL-2 and IL-4 were not detectable in any patient with JIA. Cytokine profile comparison between the 2 subsets revealed that the median IL-6 [1139 (< 4.6-2187) vs 790 (17.4-2119); p < 0.01] and IFN-g levels [235 (< 4.6-600) vs < 4.6 (< 4.6-412); p < 0.0001] were higher in ERA than in Poly-JIA. In contrast, median IL-8 levels were higher in Poly-JIA [200 (3.8-200)] compared to ERA [74.6 (4-200); p < 0.001]. However, there was no difference in levels of TNF-a, IL-1ss, and IL-12p40 between patients with these 2 subtypes of JIA.
CONCLUSION: SF levels of IL-1ss and IL-12p40 are increased in both Poly-JIA and ERA as compared to RA. IL-6 levels were higher in ERA compared to RA. Levels of TNF-a were comparable to RA in both Poly-JIA and ERA. This suggests that joint inflammation in JIA is mediated predominantly by monocytes. In ERA the levels of IL-6 and IFN-g are higher than in Poly-JIA. The increase in IFN-g in children with ERA with undetectable IL-4 suggests a Th1-dominant immune response in this disease subset.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996076

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

1.  Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study.

Authors:  Norman Ilowite; Oscar Porras; Andreas Reiff; Sue Rudge; Marilynn Punaro; Alan Martin; Roger Allen; Terry Harville; Yu-Nien Sun; Terry Bevirt; Gary Aras; Brent Appleton
Journal:  Clin Rheumatol       Date:  2008-09-03       Impact factor: 2.980

2.  Serum amyloid A induces mitogenic signals in regulatory T cells via monocyte activation.

Authors:  Khoa D Nguyen; Claudia Macaubas; Phi Truong; Nan Wang; Tieying Hou; Taejin Yoon; Elizabeth D Mellins
Journal:  Mol Immunol       Date:  2014-03-13       Impact factor: 4.407

3.  Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA).

Authors:  A Aggarwal; S Agarwal; R Misra
Journal:  Clin Exp Immunol       Date:  2007-03-21       Impact factor: 4.330

4.  Intermediate monocytes are increased in enthesitis-related arthritis, a category of juvenile idiopathic arthritis.

Authors:  P Gaur; A Myles; R Misra; A Aggarwal
Journal:  Clin Exp Immunol       Date:  2016-10-28       Impact factor: 4.330

5.  Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.

Authors:  Carol A Wallace; Edward H Giannini; Steven J Spalding; Philip J Hashkes; Kathleen M O'Neil; Andrew S Zeft; Ilona S Szer; Sarah Ringold; Hermine I Brunner; Laura E Schanberg; Robert P Sundel; Diana Milojevic; Marilynn G Punaro; Peter Chira; Beth S Gottlieb; Gloria C Higgins; Norman T Ilowite; Yukiko Kimura; Stephanie Hamilton; Anne Johnson; Bin Huang; Daniel J Lovell
Journal:  Arthritis Rheum       Date:  2011-12-19

6.  Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis.

Authors:  Shilpi Agarwal; Ramnath Misra; Amita Aggarwal
Journal:  Rheumatol Int       Date:  2008-12-04       Impact factor: 2.631

Review 7.  Enthesitis-related arthritis.

Authors:  Amita Aggarwal; Durga Prasanna Misra
Journal:  Clin Rheumatol       Date:  2015-08-02       Impact factor: 2.980

Review 8.  Oligoarticular and polyarticular JIA: epidemiology and pathogenesis.

Authors:  Claudia Macaubas; Khoa Nguyen; Diana Milojevic; Jane L Park; Elizabeth D Mellins
Journal:  Nat Rev Rheumatol       Date:  2009-10-06       Impact factor: 20.543

9.  IL-36γ in enthesitis-related juvenile idiopathic arthritis and its association with disease activity.

Authors:  Sanjukta Majumder; Shivika Guleria; Amita Aggarwal
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

10.  Possible rheumatoid arthritis subtypes in terms of rheumatoid factor, depression, diagnostic delay and emotional expression: an exploratory case-control study.

Authors:  Taavi Tillmann; Rajeev Krishnadas; Jonathan Cavanagh; K V Petrides
Journal:  Arthritis Res Ther       Date:  2013-03-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.